Arm vs. Intel: Which Technology Stock Is a Better Buy in 2026?

Arm is presented as the stronger 2026 semiconductor investment candidate after fiscal 2026 revenue rose 22.8% to $4.9B, net income reached $904M, and free cash flow was $979M, supported by its asset-light licensing model and AI/data-center expansion. Intel generated $52.9B of fiscal 2025 revenue, down 0.5%, but posted a $267M net loss and negative $4.9B free cash flow amid its capital-intensive foundry turnaround. Arm trades at substantially richer valuations, including 115.2x forward P/E versus Intel's 68.5x, while Intel faces manufacturing-execution, competitive, and shareholder-litigation risks tied to the U.S. government's roughly 10% stake.

Analysis

The relevant distinction is not ARM versus INTC headline growth, but capital intensity and the timing of AI monetization. ARM's data-center opportunity is economically attractive only as server deployments move from design wins into volume royalty shipments; that lag makes near-term estimates unusually sensitive to customer mix and royalty rate realization. At a triple-digit earnings multiple, even sustained growth can produce weak equity returns if revenue merely meets expectations rather than repeatedly raises the forward curve; SBC-adjusted free-cash-flow conversion also warrants a lower quality multiple than headline cash flow implies.

INTC is primarily an execution and financing optionality trade, not a value trade. A credible external-foundry customer, improving 18A yields, or a narrowing cash-burn trajectory could force a sharp re-rating over 1-3 months because positioning and expectations are depressed; absent those proof points, fixed-cost absorption, capex needs, and potential dilution remain the dominant variables for the next 6-18 months. TSM is the cleaner second-order beneficiary of continued Intel process delays, since prospective foundry customers cannot defer leading-edge production indefinitely and will prioritize proven capacity and yield.

Consensus appears too binary: ARM need not lose architecture share for the stock to derate, while Intel need not become a successful TSMC analogue for its equity to rally. The more likely path is ARM operationally delivering but de-rating on a slower server-royalty ramp, alongside episodic INTC rallies on manufacturing milestones that remain difficult to sustain without customer commitments. The key falsifiers are ARM reporting accelerating infrastructure royalty contribution and durable royalty-rate uplift, or INTC demonstrating external foundry backlog, yield progress, and materially lower quarterly free-cash-flow burn.

Key Decisions for Investors

• Maintain a 3-6 month relative-value short ARM / long TSM position, sized beta-neutral. The trade captures ARM's expectation risk against TSM's direct leading-edge manufacturing economics; target 15-20% relative outperformance, with a stop if ARM's next results show material infrastructure royalty acceleration plus forward guidance above consensus.
• Do not initiate a directional INTC long before independently verifiable foundry evidence. Set an alert for disclosed external customer volume commitments, 18A yield commentary, and quarterly free-cash-flow burn trending materially below the current run-rate; upon confirmation, buy a 6-12 month call spread rather than common equity to express turnaround convexity while capping dilution/cash-burn risk.
• For existing ARM exposure, reduce into strength or collar the position through the next earnings event. The near-term downside is multiple compression rather than a broken business model; reassess only if management quantifies data-center royalty contribution and demonstrates that SBC-adjusted cash generation is scaling with revenue.
• Use TSM as the preferred structural AI-foundry exposure over INTC for 6-18 months. Revisit this preference if INTC secures a meaningful third-party leading-edge customer or if geopolitical restrictions materially impair TSM's customer access and capacity utilization.